
IBSA Institut Biochimique S.A. owns 2 brands in our database. Browse the complete portfolio of IBSA Institut Biochimique S.A. subsidiaries and brands across various industries.
Company Type
private
Headquarters
Lugano, Ticino, Switzerland
Brand Portfolio
2 brands
Showing Healthcare & Pharmaceuticals brands
2 of 2 total brands
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Pharma's liquid levothyroxine oral solution, the first and only FDA-approved liquid levothyroxine, marketed in monodose ampules for hypothyroidism since 2019 in the US.
Healthcare PharmaceuticalsOwned by IBSA Institut Biochimique S.A.
IBSA Institut Biochimique SA's branded levothyroxine softgel capsule (Tirosint) and liquid solution (Tirosint-SOL), FDA approved for hypothyroidism, formulated without dyes, gluten, lactose, alcohol, or sugar, providing an excipient-free alternative to conventional levothyroxine tablets for patients with sensitivities or absorption issues.
What does IBSA own?
IBSA owns and markets pharmaceutical products across 10 therapeutic areas under three primary brand names: IBSA (corporate brand covering all therapeutic areas), Monurella (urology and urinary tract health), and Lutinus (reproductive medicine and fertility). The company's portfolio includes both prescription pharmaceuticals and consumer health products sold through pharmacies and healthcare providers.
Is IBSA publicly traded?
No, IBSA Institut Biochimique S.A. is a privately held family-owned company. It is not listed on any stock exchange and does not have public shareholders. The company has maintained its private ownership structure since its founding in 1945, which allows it to pursue long-term strategies without the pressure of public market expectations.
Who founded IBSA?
IBSA was founded in 1945 by Dott. Angelo Cavalli in Lugano, Switzerland. Cavalli established the company as a biochemical research institute. The company remained relatively small until the 1990s, when CEO and President Arturo Licenziati began a period of sustained international expansion that has continued for over 40 years.
Where is IBSA headquartered?
IBSA is headquartered in Lugano, in the canton of Ticino, Switzerland. The company's largest manufacturing facility, the cosmos plant, is also located at the Lugano headquarters. IBSA maintains additional manufacturing operations in Italy and China, along with 20 subsidiaries across Europe, China, and the United States.
How many brands does IBSA own?
IBSA owns three primary brands: IBSA (the corporate brand for pharmaceutical products across all therapeutic areas), Monurella (for urology and urinary tract health products), and Lutinus (for reproductive medicine and fertility products). The company's product portfolio spans 10 therapeutic areas, with many products marketed under the IBSA corporate brand.
Who owns IBSA?
IBSA is privately owned by the founding family. The company is controlled through private holding structures, with no external investors or parent organization. CEO and President Arturo Licenziati has led the company for 40 years, maintaining the family's ownership and strategic control. The company has never sought public listing or external investment.
What is IBSA's revenue?
IBSA reported turnover of approximately CHF 1.089 billion in its most recent disclosed figures. The company reached CHF 986 million in 2023, representing 10 percent growth over the prior year. Europe is the company's largest market, followed by the Americas, which grew at 18.3 percent in 2023. IBSA employs over 2,500 people across its global operations.
No competing brands found in the same categories. This could be because IBSA Institut Biochimique S.A.operates in unique market segments or we're still building our competitor database.
IBSA Institut Biochimique S.A. maintains a diverse portfolio of 2 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by IBSA Institut Biochimique S.A.provides valuable insights into market dynamics, product relationships, and corporate strategy.